<?xml version="1.0" encoding="UTF-8"?>
<item xmlns="http://omeka.org/schemas/omeka-xml/v5" itemId="6745" public="1" featured="0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://omeka.org/schemas/omeka-xml/v5 http://omeka.org/schemas/omeka-xml/v5/omeka-xml-5-0.xsd" uri="http://exhibits.library.stonybrook.edu/mfp/items/show/6745?output=omeka-xml" accessDate="2026-06-07T09:19:25+00:00">
  <fileContainer>
    <file fileId="6547">
      <src>http://exhibits.library.stonybrook.edu/mfp/files/original/547dda87f02e63e10815bbd8bd8b58a3.pdf</src>
      <authentication>2de3623b012b67ce51e9e637220d0b84</authentication>
      <elementSetContainer>
        <elementSet elementSetId="4">
          <name>PDF Text</name>
          <description/>
          <elementContainer>
            <element elementId="52">
              <name>Text</name>
              <description/>
              <elementTextContainer>
                <elementText elementTextId="107152">
                  <text>Role of EEG Frequency

Shift in Behavioral Effects of

Drugs

mmmm.*
During the past few years

we

have been

interested in the interrelation-

ship of changes in various measures of brain function and the behavioral
response of psychiatric patients to somatic therapies.
were devoted

Our

initial

studies

to the changes in tactile perceptual tasks in patients with

organic psychoses. This study, carried out at Bellevue Psychiatric Hospital,
demonstrated that patients with active organic psychotic reactions made

repeated errors in the simple task of reporting two simultaneously applied
cutaneous stimuli.

The

persistence of such‘errors

was

interpreted as an

index to the presence of an "organic mental syndrome."

In the

initial studies at Hillside

Heepital in 1952, the

same

patterns of errors were observed in patients receiving convulsive therapy.
we then became interested in the role of altered brain function in the
"improvement" induced by convulsive therapy.
we

In our

first

group of

patients

followed consecutive electroshock referrals with weekly measures of

changes

in brain function

of brain function:

and

memory

clinical interviews.

tests,

simultaneous

we

used four indices

tactile tests, the amobarbital

test for organic brain disease described by Weinstein and Kahn, and the
degree of induced delta activity in the EEG. It was soon apparent that
neither the memory scales nor the tactile tests were sufficiently sensitive
indicators of alteration in brain function to be satisfactory for our
purposes. The amobarbital

test,

however, was a

sensitive indicator. In

this test, the subject is asked a series of questions regarding his illness
the Department of Experimental Psychiatry, Hillside Hospital, Glen Oaks,
Island, N.Y.
Read at the Section of Neurology and Psychiatry, Queens County Medical
Society, June 3, 1958.

Frcm
Long

‘

�.2and

orientation for place, date, time

and

person. Following the

administration of intravenous amobarbital until the patient has nystagmns,
the questions are repeated. Errors of confabulation and disorientation

are scored as "positive" tests, and have been found almost exclusively in
subjects with active cerebral dysfunction. In the patients in the
electroshock series, a significant relationship was observed between
changes

in this test and impmvement ratings in convulsive therapy.

Amobarbitﬂ Test
EST

-

Improvement

#1

“----‘--- u..---.--—----—--——-we

in the

also measured the changes in
EEG.

ﬁne degree

of induced delta activity

Examination of a series of preliminary records, as well as

the description in the literature, demonstrated the early development and
‘persistence of Slow wave activity in the

EEG

during convulsive therapy.

this preliminary information, we obtained weekly records during and
‘We measured
of
treatment.
a
after course
specified leads for the per-cent
time delta, the slowest frequency, highest voltage of delta and the duration

With

of burst activity. Using these quantitative indices
180 records

activity.

in
The

we

ranked the

initial

patients according to the extent of the induced delta
upper third were classed as ”high degree delta records,"

2h

the middle third as "middle or'moderate degree delta" and the lowest third
as "low degree delta

activity."

High, Middle and

Low

Delta

-

EST

#1

�.3 When we

related the development of high degree delta activity to

improvement

rating, a signiﬁicant relationship
Fig.
EEE

was

again demonstrated.

5

Delta - Improvement -

EST

#1

---—-—------ -—------ yo--— --—‘-..- ~-

In subsequent months

development of high degrees of

third

to

EEG

delta activity during the second and

ratings. In the next table,
these observations in the next Sh patients.

weeks of treatment

have summarized

a predictive study, relating the

we embarked on

improvement

F1

.

we

6

Table: Patients High Delta 2nd, 3rd weeks of Treatment
EST

2’ 3’

’4

-_------- ----—----‘u-n-—---------_-----m-‘-----—----By

this time

we

believed that

EEG

delta activity

was

related to the

behavioral changes in convulsive therapy, and

its significance

in a control convulsive-subconvulsive study.

Of

was

tested

consecutive convulsive

therapy referrals, randomly selected patients were subjected to a course
of subconvulsive therapy instead of the convulsive therapy. This

to the patients or their therapists. 0f the

substitution

was unknown

subjects

received convulsive therapy in this series, high degree delta

who

activity records

were observed

in

of treatment. Of the 27 Subjects

3h during the second
who

to the fourth

h?

weeks

received subconvulsive therapy,

however, none demonstrated either-high or middle degree

delta activity

�.u.
EEG
.

records during any week of treatment. In concurrent behavioral

evaluations,

of the h? subjects in the convulsive group

h2

behavioral change, while only
showed such

3

showed marked

of the 27 in the subconvulsive group

a change. In clinical improvement ratings, 2h of h? were

rated "recovered" and

"much improved;" 15

"unimproved or worse."

But

as "improved" and

8

as

of the subconvulsive group,only

3

were

"recovered" and "much improved," 5 as "improved" and

19

rated

as "unimproved

cr'worse."
we were now

convinced

that high degree of

EEG

delta activity reflected

the physiologic changes essential to the behavioral change in convulsive

therapy.

An

alteration in brain function, sufficient

induce considerable

-

and of

the kind to

activity appeared to be the prerequisite,
not sufficient factor - in the convulsive therapy

EEG

a necessary, ﬂaough

slow wave

process. Perhaps a similar relationship was observable in other somatic

therapies?
we

next examined insulin

activity is induced,
hours after gavage.
receiving deep
or prolonged

which
Not

coma

therapy. During each coma,

EEG

delta

usually persists for a few minutes to a few

infrequently - in approximately 1/3 of patients

insulin therapy in our hospital, seizures, aphasia
result. After such events, EEG changes of delta activity

coma

coma

persist for days,
The relation

'

and

in cases of prolonged

between prolonged coma,

coma,

for

weeks and months.

altered brain function and

behavioral response has been discussed by numerous authors. Revitch
reported eight cases and concluded that improvement was related to the
induction of organic brain damage, similar to lobotomy. Yaeger et a1

�-5.
noted a correlation between length of coma, degree of organic confusion,
remission of mental symptoms and degree of
of prolonged coma.

EEG

In reviewing our insulin

abnormality in 12 cases

coma

experiences,

noted

we

that our best clinical results have been observed in prolonged coma cases.
As a result, it has been the intention of our staff to induce such a state.
Persistent
coma

EEG

delta activity has been observed in a small

subjects, and only in those with prolonged

neurologic signs. Thus, in insulin

coma

number of our

or persistent

also, a relation between
delta change and behavioral response is indicated.
Concurrent with these investigations, We had begun clinical

EEG

coma

investigations with the newer tranquilhers. Initial study of Raudixin

in

1953

He were

failed to indicate

any

clinical efficacy.

able to administer large doses - up to 10

With
mgm.

reserpine, however,
At these

levels,

behavioral change become prominent but so also did neurologic complications.
Parkinsonism was readily induced, and seizure induction and increased

clinical depression became prominent. The EEG changes on chronic administration were small. With our doses, desynchronization was apparent, but at
higher dosage hyperSynchrony was also noted.
With chlorpromazine, however, we were more

fortunate.

we had undertaken

a control insulin coma-chlorpromazine study, in'which the experimental
dosage called

for levels sufficient to induce clinical parkinsonism. In

three of the thirty patients grand mal seizures were induced. In

all

patients significant changes were observed in serial EEGs. These consisted
of increased modulation, increase in per-cent time alpha, and in twenty
patients lOW'voltage theta and delta activity.

On

hyperventilation, delta

�burst activity was observed.
In reviewing the experiences of others,

noted numerous reports
of chlorpremazine inducing seizures; exaggerating seizure activity in

epileptics; and activating seizure
available for reserpine.

EEG

we

records. Similar reports are

review of the electroencephalographic effects of various phreno-

A

tropics demonstrated that not all newer agents induced
Meprobamate,

in clinical doses, induces

an increase

in

activity.

slow wave
EEG

fast activity,

with increased voltage and Spindling. The records are most similar to

barbiturate records.
Benactyzine (or suavitil) induced neither slow nor

fast

activity
but desynchronized the record, with flattening of voltages and loss of
wave

whatever rhythmicity was present.

clinical experience we were impressed that chlorprcmazine
and reserpine were the most effective modifiers of psychotic behavior,
with benactyzine and meprobamate as relatively inefficient agents. It
From our

seemed

appropriate therefore to extend the neurophysiologic adaptive

hypothesis of the

it was

mode

of action of convulsive and insulin
EEG

frequencies to the delta range would

active in modifying psychotic behavior; while those that induce a

shift to the beta range, or
As a

corollary

it was

desynchronize the record would be less effective.

suggested that agents that induce no change in brain

function or changes so small as not to be reflected in serial
have

therapies;

suggested therefore, that agents that induce a change in brain

function reflected by a shift in
be most

coma

little

EEGs

would

behavioral effect. Thus, a classification of newer phrenotropic

�-7drugs based on

their

EEG

effects

was suggested:

(3) Increased slow wave activity with hypersynchrony
(b) Desynchronization with voltage and frequency irregularity,
.and
(0)

irregular theta

Increased high voltage

fast activity

In reviewing the available literature reports of promazine and perphenazine
would indicate

delta range.

that these agents induce a shift in the
Mepazine has minimal

EEG

effects,

EEG

spectrum to the

and these are

largely

desynchronization. Information regarding other newer agents was not

available.
we
EEG

have undertaken two studies based on

changes to behavior.

One

is serial

EEG

this hypothesis relating
studies of patients

receiving chronic tranquilizer medication at the hospital.
a study of the

relation

acute administration:

between the

EEG

and

A

now

second

is

the behavioral effects on

the data of our chronic administration studies

are not yet available, but the acute studies have progressed sufficiently
to danonstrate the applicability of the hypothesis.
Fbllowing the observations by Denber

derivatives, diethazine,

elicit
some
EEG

when

that

one of

the phenothiazine

administered with chlorpromazine, would

activity similar to convulsive therapy, we undertook
explorations of this compound. In the EEG laboratory with continuous
31 w wave

recording, varying amounts of diethazine from 100 to 250 mg. were

administered intravenously over a 10 minute period in psychiatric patients

at various stages of the convulsive therapy process. Instead of hyperynchrony, patients who were pretreatment and without EEG delta activity,
demonstrated significant desynchronization of the record.

�-8Fig. 7,
EEG

- Diethazine - Pretreatment

interesting, however,

Most

8

was

the effect of diethasine in patients with

increased slow wave activity during convulsive therapy. Here, too,
desynchronization became manifest, and there was a decrease in the voltage
and per-cent time

of the induced delta activity.

EEG

- Diethazine - Delta Activity

effects, we observed distinctive
behavioral changes. Patients became more irritable and restless; they
Concurrent with these

complained of sensations of

extremities. In

some,

EEG

unreality,

visual illusory

and of dysesthesias of the
phenomena and

delusional thoughts

their illness, the setting of the test procedures or our identity.
There were changes in their language patterns opposite to that previously

about

described for amobarbital, so that denial, minimization, cliches, third
person

mode and

past tense were less prominent.

The

duration of these

behavioral and language changes was from one to five hours.
changes were of similar duration

administration and disappearing

The EEG

- appearing during the period of

when

drug

the behavior had apparently reverted

to the pretreatment state.
The

ability of diethazine to

activity led to

an evaluation of

induce

other

illusory

known

and

hallucinatory

hallucinogens. In checking

�-9the literature

we

noted

that

that mescaline reversed the

Denber and Merlis had previously described
EEG

changes induced by electroshock,

in a

fashion identical with diethazine. Pennes had observed hallucinogenic

activity for another experimental compound Win 2299. We obtained some
of this material, and repeated our diethazine studies. Here, too,
Win 2299 induced EEG desynchronization associated with clinical patterns
of restlessness, excitement, hallucinatory and illusory activity.

Fig. 11,
Win 2299

We

repeated these studies with

was a

-

12
EEG

LSD, and

again the same patterns. There

difference in the time constant, but concurrent with the behavioral

effects

we

observed

EEG

changes.

Recalling the ability of benactyzine to desynchronize records,

this

compound

intravenously, and again,

we

observed the same

we

EEG

administered

pattern of

desynchronization, associated with restlessness and excitement. While

not observe the illusory and hallucinatory patterns,
kinds of language changes in these patients that

we

we

did note the

we

did

same

observed with diethazine.

�Fig. 16, 17
Benactyzine

The

chemistry of these compounds

Thus, from each of these agents,

-

EEG

is noted in the next figure:

EEG

desynchronization was induced, and

hallucinogenic or excitatory activity was observed.
we can.now

amplify our

initial

hypothesis to encompass hallucinogens.

like to refer first to conclusions described in
l9Sh by Wikler in a study of the effects of mescaline, n-allylnormorphine
In-this regard, I

and morphine

in

would

man,

in

which he

stated:

"....

regardless of the drug

administered, shifts in the pattern of electroencephalogram in the direction
of desynchronization occurred in association with anxiety, hallucinations,

fantasies, illusions or tremors, and in the direction of synchronbation.with
euphoria, relaxation or drowsiness." ‘We would now generalize our observations
of

EEG

changes and behavior to note

shift to the delta
behavior. Agents that

and

that agents that induce

EEG

synchronization

range are potent agents in the control of psychotic

induce synchronization in the beta range are relaxant,

euphoriant and sedative, while agents that desynohronize the record tend to
be

hallucinogenic.
This hypothesis lends

itself to

a variety of applications.

It provides

a bases for the understanding of the mode of action of various organic

�-11-

therapies in psychiatry.

EEG

analysis

may

also provide a basis for the

assay of new drugs and therapy procedures. Finally, these observations

permit a more rational management of the somatic therapies.

to explore each application in

summary

I would like

fashion.

application of the neurophysiologic adaptive hypothesis - for
that is the rubric under which we subsume the relationship between the
The

in brain function, reflected by the EEG, and the changes in
behavior - to insulin coma therapy has already been described. we have
changes

applied this concept to our studies of phrenotropic agents, and have
been able, both

It is

predictively

and

retrospectively, to assess

new

agents.

possible to understand lobotomy therapy, and sleep therapy,

within this framework.
As

is

for the assay of

drugs, our explorations into hallucinogens

that each of the potent hallucinogens
a biochemical similarity in a common tertiary amine radical connected

one example.

have

new

we

have recently noted

by an ethyl linkage to a large nucleus.
compounds

with this linkage.

One

On

this basis,

we

sought

for

group are known anti-parkinson agents

with anti-cholinergic properties as parsidol, artane, kemadrin, panparnit
and benadryl.

we have

not yet tested these compounds for their

EEG

or

clinical effects. Recently, Pfeiffer reported at the Academy of Neurology
that these compounds, in trained subjects, were identified most with LSD.
In 1956, Gottlieb reported that benadryl desynchronized the

patients, much as we saw this evening.
available in the literature.
shock

EEG

of electro-

Thus, some confinnation

is

�.12With regard to the

third

therapies - this hypothesis

ammﬂication

may

- the

management of somatic

be of considerable help.

In convulsive

therapy and in drug therapies, the patient'who responds in a favorable

fashion is‘no problem. But what of the patients

who

responds poorly,

or not at all? Could the failure of response be related to inadequate
dosage?

In electroshock,

when a

patient manifests paranoid or withdrawal

behavior, or no significant change, an

If

the record

we may assume

fails to

EEG

provides a guide to management.

demonstrate high voltage slow wave

that treatment has been inadequate,

activity, then

and continue the

treatnent course or increase the frequency or alter the convulsant
method.

If

EEG

changes are present, then we would assume

that other

factors - personality, sociologic or interpersonal - are not conducive
to "improvement" by electroshock, and other remedies sought. Similar
applications are possible for phrenotropic agents.
In summary,

we

believe that somatic therapies in psychiatry exert

their effects primarily by altering brain function. Changes in the
EEG Spectrum are one reflection of sudatalteration and are useful as
a guide to the mode of action, effectiveness and application of somatic

therapies.

�</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </file>
  </fileContainer>
  <collection collectionId="3">
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="3">
                <text>Research Files and Unpublished Works</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
  </collection>
  <elementSetContainer>
    <elementSet elementSetId="1">
      <name>Dublin Core</name>
      <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
      <elementContainer>
        <element elementId="50">
          <name>Title</name>
          <description>A name given to the resource</description>
          <elementTextContainer>
            <elementText elementTextId="67444">
              <text>Role of EEG Frequency Shift in Behavioral Effects of Drugs, 1958</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="51">
          <name>Type</name>
          <description>The nature or genre of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="67445">
              <text>Text</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="43">
          <name>Identifier</name>
          <description>An unambiguous reference to the resource within a given context</description>
          <elementTextContainer>
            <elementText elementTextId="67446">
              <text>mfp-03-01-002-12-011</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="40">
          <name>Date</name>
          <description>A point or period of time associated with an event in the lifecycle of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="67447">
              <text>1958</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="39">
          <name>Creator</name>
          <description>An entity primarily responsible for making the resource</description>
          <elementTextContainer>
            <elementText elementTextId="67448">
              <text>&lt;a title="Fink, Max, 1923-" href="http://id.loc.gov/authorities/names/n79039548" target="_blank"&gt;Fink, Max, 1923-&lt;/a&gt;</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="49">
          <name>Subject</name>
          <description>The topic of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="67449">
              <text>&lt;a href="http://id.loc.gov/authorities/subjects/sh85113021"&gt;Research Files&lt;/a&gt; and Unpublished Works -- Hillside Hospital, Glen Oaks, NY, 1953-1965</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="46">
          <name>Relation</name>
          <description>A related resource</description>
          <elementTextContainer>
            <elementText elementTextId="67450">
              <text>The Max Fink Collection</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="41">
          <name>Description</name>
          <description>An account of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="67451">
              <text>Research papers, files, and related correspondence</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="47">
          <name>Rights</name>
          <description>Information about rights held in and over the resource</description>
          <elementTextContainer>
            <elementText elementTextId="67452">
              <text>&lt;a title="IN COPYRIGHT - EDUCATIONAL USE PERMITTED" href="http://rightsstatements.org/vocab/InC-EDU/1.0/" target="_blank"&gt;IN COPYRIGHT - EDUCATIONAL USE PERMITTED&lt;/a&gt;</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="48">
          <name>Source</name>
          <description>A related resource from which the described resource is derived</description>
          <elementTextContainer>
            <elementText elementTextId="67453">
              <text>Special Collections and University Archives, University Libraries. Stony Brook University Libraries (State University of New York).</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="44">
          <name>Language</name>
          <description>A language of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="80947">
              <text>en-US</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="42">
          <name>Format</name>
          <description>The file format, physical medium, or dimensions of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="87508">
              <text>application/pdf</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="45">
          <name>Publisher</name>
          <description>An entity responsible for making the resource available</description>
          <elementTextContainer>
            <elementText elementTextId="94069">
              <text/>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="37">
          <name>Contributor</name>
          <description>An entity responsible for making contributions to the resource</description>
          <elementTextContainer>
            <elementText elementTextId="100630">
              <text/>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </elementSet>
  </elementSetContainer>
  <tagContainer>
    <tag tagId="3">
      <name>Research</name>
    </tag>
  </tagContainer>
</item>
